CND
Commission on Narcotic Drugs
President: Mariana Carolina Guerrero Zárate
Chair: Arantxa Leticia Rodríguez, Iván García Heredia, Yaretzi Benítez Mendoza, Salma Arredondo Escandón, Arantza Estrada Rios.
Topic A) Strategies to reduce the trafficking and consumption of synthetic drugs within Latin American prisons due to the inadequate penitentiary security systems, with an emphasis on the Federative Republic of Brazil
Topic B) Measures to reduce the production of synthetic drugs due to the presence of drug trafficking groups in rural areas of Latin America, focusing on illicit coca leaf in the Republic of Peru and the Republic of Colombia
Background and faculties
The United Nations Commission on Narcotic Drugs was created in 1946 as part of resolution 9(I) established by the Economic and Social Council (ECOSOC), to assist in overseeing the correct application of international drug treaties. Likewise, it provides resolutions to improve the control of psychotropic drugs through their coordination and regulation, promoting international and regional cooperation. The CND works with two different segments: an operational segment that serves as the governing body of the United Nations Office on Drugs and Crime (UNODC); and a segment that performs regulatory functions from treaties, administrative aspects and active matters. The CND has 5 regional groups and it is made up of 53 Member States. Furthermore, for its proper functioning, the Commission Board is established; which includes the presidents of each of the 5 regional groups, one from the European Union and one from China.
The United Nations Commission on Narcotic Drugs in order to avoid misuse of pharmaceutical substances and drug trafficking is entitled to:
-
Supervise, review and modify existing international policies for the control of narcotic substances, through annual sessions.
-
Oversee the correct implementation of international narcotic treaties, in addition to the elaboration of periodic reports on the actions and policies taken by the member countries in relation to drug control.
-
Create global guidelines and policies to support the fight against drug abuse and illicit trafficking.
-
Technical advice to member countries to strengthen their drug control capabilities; along with the facilitation of assistance, treatment and rehabilitation programs for affected people by drug consumption.
-
Scientific reviews on the classification and control of new substances, taking into account their danger, their potential for abuse and their medical usefulness; as well as collection of data on its production and trafficking, analyzing their consumption trends.
-
Develops educational materials as well as prevention campaigns to raise public awareness about the risks associated with substance abuse.
-
Promotes international cooperation to carry on strategic operations.